Combination of N-(4-hydroxyphenyl) retinamide and genistein increased apoptosis in neuroblastoma SK-N-BE2 and SH-SY5Y xenografts

Neuroscience

Volumn 163, Issue 1, 2009, Pages 286-295

  Karmakar, S ^a   Roy Choudhury, S ^a   Banik, N L ^b   Ray, S K ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

apoptosis; caspases; genistein; N (4 hydroxyphenyl) retinamide; neuroblastoma

Indexed keywords

BACULOVIRUS INHIBITOR OF APOPTOSIS REPEAT CONTAINING PROTEIN 2; BACULOVIRUS INHIBITOR OF APOPTOSIS REPEAT CONTAINING PROTEIN 3; CALPAIN; CASPASE 12; CASPASE 3; FENRETINIDE; FIBROBLAST GROWTH FACTOR 2; GENISTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; PROTEIN BAX; PROTEIN BCL 2; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER SIZE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; LIVER TOXICITY; MOUSE; NEPHROTOXICITY; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; TUMOR XENOGRAFT; WEIGHT REDUCTION;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BODY WEIGHT; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; GENISTEIN; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, NUDE; NEUROBLASTOMA; NF-KAPPA B; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME; TRETINOIN; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 68349144682     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.06.037     Document Type: Article

References (50)

1. Baj G., and Tongiorgi E. BDNF splice variants from the second promoter cluster support cell survival of differentiated neuroblastoma upon cytotoxic stress. J Cell Sci 122 (2009) 36-43
2. Baumann Kubetzko F.B., Di Paolo C., Maag C., Meier R., Schäfer B.W., Betts D.R., Stahel R.A., and Himmelmann A. The PAX5 oncogene is expressed in N-type neuroblastoma cells and increases tumorigenicity of a S-type cell line. Carcinogenesis 25 (2004) 1839-1846
3. Bian X., McAllister-Lucas L.M., Shao F., Schumacher K.R., Feng Z., Porter A.G., Castle V.P., and Opipari Jr. A.W. NF-kB activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells. J Biol Chem 276 (2001) 48921-48929
4. Brodeur G.M. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3 (2003) 203-216
5. Camerini T., Mariani L., De Palo G., Marubini E., Di Mauro M.G., Decensi A., Costa A., and Veronesi U. Safety of the synthetic retinoid fenretinide: long-term results from a controlled clinical trial for the prevention of contralateral breast cancer. J Clin Oncol 19 (2001) 1664-1670
6. Carter A.B., Monick M.M., and Hunninghake G.W. Lipopolysaccharide-induced NF-kB activation and cytokine release in human alveolar macrophages is PKC-independent and TK- and PC-PLC-dependent. Am J Respir Cell Mol Biol 18 (1998) 384-391
7. Chen S., Samuel W., Fariss R.N., Duncan T., Kutty R.K., and Wiggert B. Differentiation of human retinal pigment epithelial cells into neuronal phenotype by N-(4-hydroxyphenyl) retinamide. J Neurochem 84 (2003) 972-981
8. Cregan S.P., Dawson V.L., and Slack R.S. Role of AIF in caspase-dependent and caspase-independent cell death. Oncogene 23 (2004) 2785-2796
9. Das A., Banik N.L., and Ray S.K. Mechanism of apoptosis with the involvement of calpain and caspase cascades in human malignant neuroblastoma SH-SY5Y cells exposed to flavonoids. Int J Cancer 119 (2006) 2575-2585
10. Das A., Banik N.L., and Ray S.K. N-(4-hydroxyphenyl) retinamide induced both differentiation and apoptosis in human glioblastoma T98G and U87MG cells. Brain Res 1227 (2008) 207-215
11. Das A., Banik N.L., and Ray S.K. Retinoids induce differentiation and down regulate telomerase activity and N-Myc to increase sensitivity to flavonoids for apoptosis in human malignant neuroblastoma SH-SY5Y cells. Int J Oncol 34 (2009) 757-765
12. Dijsselbloem N., Goriely S., Albarani V., Gerlo S., Francoz S., Marine J.C., Goldman M., Haegeman G., and Vanden Berghe W. A critical role for p53 in the control of NF-kB-dependent gene expression in TLR4-stimulated dendritic cells exposed to genistein. J Immunol 178 (2007) 5048-5057
13. Du C., Fang M., Li Y., Li L., and Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102 (2000) 33-42
14. Geng Y., Zhang B., and Lotz M. Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes. J Immunol 151 (1993) 6692-6700
15. Goldschneider D., Horvilleur E., Plassa L.F., Guillaud-Bataille M., Million K., Wittmer-Dupret E., Danglot G., de Thé H., Bénard J., May E., and Douc-Rasy S. Expression of C-terminal deleted p53 isoforms in neuroblastoma. Nucleic Acids Res 34 (2006) 5603-5612
16. Gong L., Li Y., Nedeljkovic-Kurepa A., and Sarkar F.H. Inactivation of NF-kB by genistein is mediated via Akt signaling pathway in breast cancer cells. Oncogene 22 (2003) 4702-4709
17. Hail Jr. N., Kim H.J., and Lotan R. Mechanisms of fenretinide-induced apoptosis. Apoptosis 11 (2006) 1677-1694
18. Hewson Q.D., Lovat P.E., Corazzari M., Catterall J.B., and Redfern C.P. The NF-kB pathway mediates fenretinide-induced apoptosis in SH-SY5Y neuroblastoma cells. Apoptosis 10 (2005) 493-498
19. Ho K.P., Li L., Zhao L., and Qian Z.M. Genistein protects primary cortical neurons from iron-induced lipid peroxidation. Mol Cell Biochem 247 (2003) 219-222
20. Kang J.S., Yoon Y.D., Han M.H., Han S.B., Lee K., Kang M.R., Moon E.Y., Jeon Y.J., Park S.K., and Kim H.M. Estrogen receptor-independent inhibition of tumor necrosis factor-a gene expression by phytoestrogen equol is mediated by blocking nuclear factor-kB activation in mouse macrophages. Biochem Pharmacol 71 (2005) 136-143
21. Karmakar S., Banik N.L., Patel S.J., and Ray S.K. Combination of all-trans retinoic acid and taxol regressed glioblastoma T98G xenografts in nude mice. Apoptosis 12 (2007) 2077-2087
22. Karmakar S., Banik N.L., and Ray S.K. Combination of all-trans retinoic acid and paclitaxel induced differentiation and apoptosis in human glioblastoma U87MG xenografts in nude mice. Cancer 112 (2008) 596-607
23. Karmakar S., Weinberg M.S., Banik N.L., Patel S.J., and Ray S.K. Activation of multiple molecular mechanisms for apoptosis in human malignant glioblastoma T98G and U87MG cells treated with sulforaphane. Neuroscience 141 (2006) 1265-1280
24. Kim M.H. Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases. J Cell Biochem 89 (2003) 529-538
25. LaCasse E.C., Baird S., Korneluk R.G., and MacKenzie A.E. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 17 (1998) 3247-3259
26. Li Z., Li J., Mo B., Hu C., Liu H., Qi H., Wang X., and Xu J. Genistein induces cell apoptosis in MDA-MB-231 breast cancer cells via the mitogen-activated protein kinase pathway. Toxicol In Vitro 22 (2008) 1749-1753
27. Lotan R. Retinoids in cancer chemoprevention. FASEB J 10 (1996) 1031-1039
28. Makin G.W., Corfe B.M., Griffiths G.J., Thistlethwaite A., Hickman J.A., and Dive C. Damage-induced Bax N-terminal change, translocation to mitochondria and formation of Bax dimers/complexes occur regardless of cell fate. EMBO J 20 (2001) 6306-6315
29. Maris J.M., and Matthay K.K. Molecular biology of neuroblastoma. J Clin Oncol 17 (1999) 2264-2279
30. Okuno M., Kojima S., Matsushima-Nishiwaki R., Tsurumi H., Muto Y., Friedman S.L., and Moriwaki H. Retinoids in cancer chemoprevention. Curr Cancer Drug Targets 4 (2004) 285-298
31. Polster B.M., Basañez G., Etxebarria A., Hardwick J.M., and Nicholls D.G. Calpain I induces cleavage and release of apoptosis-inducing factor from isolated mitochondria. J Biol Chem 280 (2005) 6447-6454
32. Rao R.V., Castro-Obregon S., Frankowski H., Schuler M., Stoka V., del Rio G., Bredesen D.E., and Ellerby H.M. Coupling endoplasmic reticulum stress to the cell death program. An Apaf-1-independent intrinsic pathway. J Biol Chem 277 (2002) 21836-21842
33. Reynolds C.P., and Lemons R.S. Retinoid therapy of childhood cancer. Hematol Oncol Clin North Am 15 (2001) 867-910
34. Reynolds C.P., Matthay K.K., Villablanca J.G., and Maurer B.J. Retinoid therapy of high-risk neuroblastoma. Cancer Lett 197 (2003) 185-192
35. Ribatti D., Alessandri G., Baronio M., Raffaghello L., Cosimo E., Marimpietri D., Montaldo P.G., De Falco G., Caruso A., Vacca A., and Ponzoni M. Inhibition of neuroblastoma-induced angiogenesis by fenretinide. Int J Cancer 94 (2001) 314-321
36. Sabichi A.L., Xu H., Fischer S., Zou C., Yang X., Steele V.E., Kelloff G.J., Lotan R., and Clifford J.L. Retinoid receptor-dependent and independent biological activities of novel fenretinide analogues and metabolites. Clin Cancer Res 9 (2003) 4606-4613
37. 2+-mediated, calpain/caspase-12-dependent apoptosis in breast cancer cells. Biochem Biophys Res Commun 321 (2004) 462-467
38. Shishodia S., Gutierrez A.M., Lotan R., and Aggarwal B.B. N-(4-hydroxyphenyl) retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through downregulation of IkBa kinase and nuclear factor-kB-regulated gene products. Cancer Res 65 (2005) 9555-9565
39. Sonee M., Sum T., Wang C., and Mukherjee S.K. The soy isoflavone, genistein, protects human cortical neuronal cells from oxidative stress. Neurotoxicology 25 (2004) 885-891
40. Sun S.Y., and Lotan R. Retinoids and their receptors in cancer development and chemoprevention. Crit Rev Oncol Hematol 41 (2002) 41-55
41. Tabary O., Escotte S., Couetil J.P., Hubert D., Dusser D., Puchelle E., and Jacquot J. Genistein inhibits constitutive and inducible NF-kB activation and decreases IL-8 production by human cystic fibrosis bronchial gland cells. Am J Pathol 155 (1999) 473-481
42. Tiwari M., Kumar A., Sinha R.A., Shrivastava A., Balapure A.K., Sharma R., Bajpai V.K., Mitra K., Babu S., and Godbole M.M. Mechanism of 4-HPR-induced apoptosis in glioma cells: evidences suggesting role of mitochondrial-mediated pathway and endoplasmic reticulum stress. Carcinogenesis 27 (2006) 2047-2058
43. Tophkhane C., Yang S., Bales W., Archer L., Osunkoya A., Thor A.D., and Yang X. Bcl-2 overexpression sensitizes MCF-7 cells to genistein by multiple mechanisms. Int J Oncol 31 (2007) 867-874
44. Vandesompele J., Edsjö A., De Preter K., Axelson H., Speleman F., and Påhlman S. ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value. Oncogene 22 (2003) 456-460
45. Voigt A., and Zintl F. Effects of retinoic acid on proliferation, apoptosis, cytotoxicity, migration, and invasion of neuroblastoma cells. Med Pediatr Oncol 40 (2003) 205-213
46. Wang C.Y., Mayo M.W., Korneluk R.G., Goeddel D.V., and Baldwin Jr. A.S. NF-kB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281 (1998) 1680-1683
47. Wang X., Chen S., Ma G., Ye M., and Lu G. Genistein protects dopaminergic neurons by inhibiting microglial activation. Neuroreport 16 (2005) 267-270
48. Wang Z., Zhang Y., Banerjee S., Li Y., and Sarkar F.H. Inhibition of NF-kB activity by genistein is mediated via Notch-1 signaling pathway in pancreatic cancer cells. Int J Cancer 118 (2006) 1930-1936
49. Wei H., Wei L., Frenkel K., Bowen R., and Barnes S. Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutr Cancer 20 (1993) 1-12
50. Yeh T.C., Chiang P.C., Li T.K., Hsu J.L., Lin C.J., Wang S.W., Peng C.Y., and Guh J.H. Genistein induces apoptosis in human hepatocellular carcinomas via interaction of endoplasmic reticulum stress and mitochondrial insult. Biochem Pharmacol 73 (2007) 782-792